Earnings
Weight-Loss Drug Stocks Diverge After Earnings and Guidance
Shares of Eli Lilly surged while Novo Nordisk fell sharply and Amgen advanced after earnings, highlighting how guidance and demand visibility—not just results—are shaping investor reaction across obesity and biotech stocks.